| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 08/31/1993 | CA1321764C Dna sequence to target proteins to the mammary gland for efficient secretion |
| 08/25/1993 | EP0556345A1 Retroviral vectors useful for gene therapy. |
| 08/25/1993 | EP0556231A1 Method and composition for controlling proliferation of cells |
| 08/25/1993 | EP0556197A1 Prolonging expression of polynucleotides introduced into a cell |
| 08/24/1993 | US5239060 Muscular dystrophy protein, dystrophin |
| 08/19/1993 | WO1993016179A1 MAMMALIAN Sos - A REGULATOR/EFFECTOR OF TYROSINE KINASE SIGNALLING |
| 08/19/1993 | WO1993016177A1 Homogenotization of gene-targeting events |
| 08/19/1993 | WO1993015743A1 Novel gene therapies employing antisense constructs |
| 08/19/1993 | WO1993015609A1 Interferon gene therapy for the treatment of vascular disorders |
| 08/19/1993 | CA2131550A1 Interferon gene therapy for the treatment of vascular disorders |
| 08/18/1993 | EP0555397A1 Polypeptide with kd hmfg differentiation antigen binding specificity |
| 08/18/1993 | EP0555385A1 Agents and methods for binding to elam-1 |
| 08/18/1993 | EP0555370A1 Methods and applications for efficient genetic suppressor elements |
| 08/17/1993 | CA1321363C Application of oligonucleotides linked to an intercalating agent, especially as a drug |
| 08/11/1993 | EP0554376A1 Dna construct for providing rna therapy |
| 08/11/1993 | EP0554352A1 A method for transplanting cells into the brain and therapeutic uses therefor |
| 08/11/1993 | EP0554344A1 Pharmaceutical composition for the treatment or prevention of a malignant tumor |
| 08/05/1993 | WO1993015209A1 Human epidermal gene promoter |
| 08/05/1993 | WO1993015207A2 Hepatitis therapeutics |
| 08/05/1993 | WO1993015199A1 Novel biologically active polypeptides, preparation thereof and pharmaceutical composition containing said polypeptides |
| 08/05/1993 | WO1993015187A1 Nucleozymes |
| 08/05/1993 | WO1993015185A1 GENE TRANSFER IN POULTRY BY INTRODUCTION OF EMBRYO CELLS $i(IN OVO) |
| 08/05/1993 | WO1993014790A1 A method for transplanting cells into the brain and therapeutic uses therefor |
| 08/05/1993 | WO1993014778A1 Ex vivo gene transfer |
| 08/05/1993 | WO1993014769A1 Method for making universal donor cells |
| 08/05/1993 | WO1993014629A1 Gene transfer in birds by introduction of dna into muscle in ovo |
| 08/05/1993 | WO1993012781A3 Creatine analogs having antiviral activity |
| 08/05/1993 | CA2129119A1 Nucleozymes |
| 08/05/1993 | CA2128896A1 Hepatitis therapeutics |
| 08/05/1993 | CA2128630A1 A method for transplanting cells into the brain and therapeutic uses therefor |
| 08/05/1993 | CA2128616A1 Ex vivo gene transfer |
| 08/05/1993 | CA2126692A1 Method for making universal donor cells |
| 08/05/1993 | CA2117429A1 Gene transfer in birds by introduction of dna into muscle in ovo |
| 08/04/1993 | EP0553235A1 Targeting viruses and cells for selective internalization by cells |
| 08/04/1993 | EP0553088A1 Promotion of maturation of hematopoietic progenitor cells |
| 07/28/1993 | EP0552767A2 3'-derivatised oligonucleotide analogues with non-nucleotidic groups, their preparation and use |
| 07/28/1993 | EP0552766A2 Oligonucleotide analogues, their preparation and use |
| 07/22/1993 | WO1993014218A1 Enzymatic rna molecules |
| 07/22/1993 | WO1993014201A1 Dna encoding a human 5-ht1f receptor and uses thereof |
| 07/22/1993 | WO1993014188A1 Targeted virus |
| 07/22/1993 | WO1993014172A1 Microcapsule-containing spray can |
| 07/22/1993 | WO1993013807A1 A method of administering genetically engineered endothelial cells to sites of angiogenesis for effecting genetic therapy |
| 07/22/1993 | WO1993013805A1 Cytotoxic drug therapy |
| 07/22/1993 | WO1993013785A1 Induced tolerance to xenografts |
| 07/22/1993 | CA2127461A1 Enzymatic rna molecules |
| 07/22/1993 | CA2126094A1 Induced tolerence to xenografts |
| 07/22/1993 | CA2105284A1 Dna encoding a human 5-ht 1f receptor and uses thereof |
| 07/21/1993 | EP0551294A1 Ribozyme inhibition of bcr-abl gene expression |
| 07/14/1993 | EP0550482A1 Methods for inhibiting rejection of transplanted tissue |
| 07/08/1993 | WO1993013121A1 Gapped 2' modified oligonucleotides |
| 07/08/1993 | WO1993013114A1 COMPOSITIONS AND METHODS FOR MODULATING β-AMYLOID |
| 07/08/1993 | WO1993012814A2 Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations |
| 07/08/1993 | WO1993012781A2 Creatine analogs having antiviral activity |
| 07/08/1993 | WO1993012756A2 Transfection of lung via aerosolized transgene delivery |
| 07/08/1993 | CA2126686A1 Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations |
| 07/08/1993 | CA2126451A1 Compositions and methods for modulating .beta.-amyloid |
| 07/08/1993 | CA2125563A1 Creatine analogs having antiviral activity |
| 07/07/1993 | EP0549723A1 Packaging cells |
| 07/07/1993 | EP0549691A1 Gene therapy for cystic fibrosis |
| 07/07/1993 | EP0549673A1 Viral growth inhibition |
| 07/07/1993 | EP0549615A1 Sugar modified oligonucleotides that detect and modulate gene expression |
| 07/06/1993 | US5225347 Therapeutic ribozyme compositions and expression vectors |
| 06/30/1993 | EP0548234A1 Cloning of chicken anaemia dna |
| 06/30/1993 | EP0528842A4 Methods of tissue implantation |
| 06/24/1993 | WO1993012251A1 Senescent cell derived inhibitors of dna synthesis |
| 06/24/1993 | WO1993012240A1 Gene therapy for cystic fibrosis transmembrane conductance regulator activity (cftr) |
| 06/24/1993 | WO1993012129A1 Peptide nucleic acids and their effect on genetic material |
| 06/24/1993 | CA2126101A1 Gene therapy for cystic fibrosis transmembrane conductance regulator activity (cftr) |
| 06/24/1993 | CA2125966A1 Peptide nucleic acids and their effect on genetic material |
| 06/22/1993 | US5221736 Sequential peptide and oligonucleotide syntheses using immunoaffinity techniques |
| 06/16/1993 | EP0546054A1 LIGAND FOR THE c-KIT RECEPTOR AND METHODS OF USE THEREOF |
| 06/16/1993 | EP0531436A4 Sequence-specific nonphotoactivated crosslinking agents which bind to the major groove of duplex dna |
| 06/15/1993 | US5219740 Genetic engineering for mammalian implants |
| 06/10/1993 | WO1993011230A1 Modified mammalian stem cell blocking viral replication |
| 06/10/1993 | WO1993011228A1 Repopulation of testicular seminiferous tubules with foreign cells |
| 06/10/1993 | WO1993011147A1 Dna encoding a human 5-ht1e receptor and uses thereof |
| 06/10/1993 | WO1993010820A1 Enhanced triple-helix and double-helix formation with oligomers containing modified pyrimidines |
| 06/10/1993 | WO1993010814A1 Anti-cancer immunotherapeutic vector constructs |
| 06/10/1993 | WO1993010805A1 Inhibitory immunoglobulin polypeptides to human pdgf beta receptor |
| 06/10/1993 | CA2125161A1 Repopulation of testicular seminiferous tubules with foreign cells, corresponding resultant germ cells, and corresponding resultant animals and progeny |
| 06/10/1993 | CA2101162A1 Dna encoding a human 5-ht1e receptor and uses thereof |
| 06/09/1993 | EP0545016A1 Composition for nucleic acid complex transfer in suspension eukaryotic cells |
| 06/09/1993 | EP0544716A1 Oligonucleotide modulation of cell adhesion |
| 06/09/1993 | EP0478708A4 Formation of triple helix complexes of double stranded dna using nucleoside oligomers |
| 06/09/1993 | DE4140003A1 DNA encoding low mol.wt. glutaminase - used for glutamine isolation from human tissues or fluids for treating cancer and HIV |
| 06/08/1993 | US5217889 Randomly fragmenting DNA homologous to gene to be supressed, transferring fragments to expression vectors, introducing supressor library into living cells, isolating modified cells and obtaining supressor element from cells |
| 06/02/1993 | EP0543938A1 Inhibition of influenza virus type a, ann arbor strain h2n2 by antisense oligonucleotides |
| 05/27/1993 | WO1993010244A1 Synthetic alpha-l-iduronidase and genetic sequences encoding same |
| 05/27/1993 | WO1993010234A1 Therapy of central nervous system by genetically modified cells |
| 05/27/1993 | WO1993010227A1 Transgenic animals lacking prion proteins |
| 05/27/1993 | WO1993010219A1 Cellular composition for the treatment of human or animal organisms |
| 05/27/1993 | WO1993009815A1 Specific tolerance in transplantation |
| 05/27/1993 | WO1993009812A1 MURINE MONOCLONAL ANTIBODY (5c8) RECOGNIZES A HUMAN GLYCOPROTEIN ON THE SURFACE OF T-LYMPHOCYTES |
| 05/27/1993 | WO1993009789A1 Treatment of melanoma with antisense oligonucleotides to c-myb proto-oncogene |
| 05/27/1993 | CA2378820A1 Murine monoclonal antibody (5c8) recognizes a human glycoprotein on the surface of t-lymphocytes |
| 05/27/1993 | CA2123611A1 Treatment of melanoma with antisense oligonucleotides to c-myb proto-oncogene |
| 05/26/1993 | EP0542887A1 Psoralen conjugated methylphosphonate oligonucleotides as therapeutic agents for chronic myelogenous leukemia |
| 05/26/1993 | EP0542822A1 Viral (hiv) growth inhibition |
| 05/25/1993 | US5214031 Prophylaxis and treatment of alzheimer's disease |
| 05/19/1993 | EP0541722A1 Compounds and methods for inhibiting gene expression. |